The analgesic effect of trans-resveratrol is regulated by calcium channels in the hippocampus of mice
- 317 Downloads
Resveratrol has been widely studied in terms of it’s potential to slow the progression of many diseases. But little is known about the mechanism of action in neuropathic pain. Neuropathic pain is the main type of chronic pain associated with tissue injury. Calcium channels and calcium/caffeine-sensitive pools are associated with analgesic pathway involving neuropathic pain. Our previous study suggested that the antinociceptive effect of resveratrol was involved in Ca2+/calmodulin-dependent signaling in the spinal cord of mice. The aim of this study was to explore the involvement of Ca2+ in analgesic effects of trans-resveratrol in neuropathic pain and signal pathway in hippocampus. Hot plate test was used to assess antinociceptive response when mice were treated with trans-resveratrol alone or in combination with Mk 801, nimodipine, CaCl2, ryanodine or EGTA. The effects of trans-resveratrol and the combination on Ca2+/calmodulin-dependent protein kinase II (CaMKII) and BDNF (brain-derived neurotrophic factor) expression in hippocampus were also investigated. The results showed that trans-resveratrol increased paw withdraw latency in the hot plate test. The effect of resveratrol was enhanced by Mk 801 and nimodipine. Central administration of Ca2+, however, abolished the antinociceptive effects of resveratrol. In contrast, centrally administered EGTA or ryanodine improved trans-resveratrol induced antinociception. There was a significant increase in p-CaMKII and BDNF expression in the hippocampus when resveratrol were combined with Mk 801, nimodipine, ryanodine and EGTA. Administration of CaCl2 blocked changes in p-CaMKII and BDNF levels in the hippocampus. These findings suggest that trans-resveratrol exerts the effects of antinociception through regulation of calcium channels and calcium/caffeine-sensitive pools.
KeywordsTrans-resveratrol Antinociceptive Calcium channels Calcium/caffeine-sensitive pools CaMKII BDNF
This project was supported by the Natural Science Foundation of Zhejiang Province(NO.LY15H090003)and the Public Applied Research of Zhejiang Province(NO.2016F82SA100042)to Dr. G. Wang. This work was also supported by the National Natural Science Foundation for the Youth (NSFY 81400600) and Zhejiang province key science and technology innovation team (2013TD13) to Dr. YC Yu. The authors do not have financial or personal conflicts of interest associated with this work.
- Eisenach JC, Zhang Y, Duflo F (2005) Alpha2-adrenoceptors inhibit the intracellular Ca2+ response to electrical stimulation in normal and injured sensory neurons, with increased inhibition of calcitonin gene-related peptide expressing neurons after injury. Neuroscience 131:187–197CrossRefGoogle Scholar
- Haley TJ, McCormick WG (1957) Pharmacological effects produced by interacerebral injections of drugs in the conscious mouse. Br J Pharmacol 12(1):12–15Google Scholar
- Harris RA, Loh HH, Way EL (1975) Effects of divalent cations, cation chelators and an ionophore on morphine analgesia and tolerance. J Pharmcol Exp Ther 195:488–498Google Scholar
- da Matta CB, de Souza ET, de Queiroz AC, de Lira DP, de Araújo MV, Cavalcante-Silva LH, de Miranda GE, de Araújo-Júnior JX, Barbosa-Filho JM, de Oliveira Santos BV, Alexandre-Moreira MS (2011) Antinociceptive and anti-inflammatory activity from algae of the genus Caulerpa. Mar Drugs 9:307–318CrossRefPubMedPubMedCentralGoogle Scholar
- Rousseau E, Smith JS, Meissner G (1987) Ryanodine modifies conductance and gating behavior of single Ca2+ release channel. Am J Phys 253:C364–C368Google Scholar